Skip to main content
. 2018 Feb 16;43(2):272–281. doi: 10.1016/j.jgr.2018.02.006

Fig. 1.

Fig. 1

(A) Scheme of experiment. (B) Lateral line for zebrafish. (C) Number of trunk neuromasts of alloxan dose-dependently damaged zebrafish. (D) Fluorescent microscopic image of trunk neuromast following treatment with 0.1 YO-PRO (*p < 0.05, **p < 0.01, ***p < 0.001; compared to normal (NOR) zebrafish).